A carregar...
Clinical role of obinutuzumab in the treatment of naive patients with chronic lymphocytic leukemia
The introduction of targeted therapy against CD20(+) with the monoclonal antibody rituximab has dramatically improved the survival of B-cell non-Hodgkin lymphoma including chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma. Unfortunately, CLL remains incurable with chemoimmunotherapy, wit...
Na minha lista:
| Publicado no: | Biologics |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove Medical Press
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4337412/ https://ncbi.nlm.nih.gov/pubmed/25733804 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BTT.S61600 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|